Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,918
+$100 QoQ
Shares Held
25
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,571
of 1,603 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DecisionPoint Financial, LLC holds $178,833 across 10 Drug Manufacturers - General names. NVS ranks #4 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
442 | $112,254 | |
| 2 | LLY |
ELI LILLY & Co
|
28 | $33,584 | |
| 3 | MRK |
Merck & Co., Inc.
|
143 | $18,375 | |
| 4 | NVS |
Novartis AG
This page
|
25 | $3,918 | |
| 5 | ABBV |
AbbVie Inc.
|
13 | $3,271 | |
| 6 | AMGN |
Amgen Inc
|
6 | $2,172 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
13 | $1,642 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
24 | $1,382 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,918 | 25 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,818 | 25 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,446 | 25 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,206 | 25 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||